The AstraZeneca vaccine, expected to last until the middle of the year, will expire by April, and to add to the bad news, it might not be that effective against the 501Y.V2 variant.
The first batch of vaccines has arrived, but it’s going to take at least two weeks for them to be checked and verified. In the meantime, the government has launched its Electronic Vaccination Data System.
Yesterday, the first batch of COVID-19 vaccines arrived on South African soil, with news outlets carrying live feeds, and politicians on the scene patting each other on the backs.
Many South Africans have explicitly stated that they would not take a COVID-19 vaccine, but how does this impact the workplace?
As with any vaccine, there will always be those who say that they won’t be taking it, but the consequences of that decision could be dire.
As if there weren’t already enough issues when it comes to bringing the Oxford-AstraZeneca COVID-19 vaccine to South Africa, the price just went up.
Bloomberg decided to tackle some of the most common concerns related to the COVID-19 vaccines, and their possible side-effects.
The Western Cape government has outlined its three-phase plans for vaccine distribution, as well as how the process should unfold.
Roughly half of the country says it won’t take the vaccine jab, which is well short of the 67% needed to make it effective. Should vaccines be mandatory, then?
South Africa missed the deadline to secure vaccines through the Covax programme, but a plan of sorts is in place to remedy that.
The Australian government has terminated its agreement with biotech company CSL Limited, which was due to provide 51 million doses of a COVID-19 vaccine.
People with a history of significant allergic reactions should not have the Pfizer/BioNTech jab just yet, regulators say, after two NHS workers had allergic reactions earlier this week.
People can’t get enough of Martin Kenyon, who after his viral CNN interview, went on to put Piers Morgan in his place on ‘Good Morning Britain’.
The promise of a vaccine has given rise to a number of questions, including whether or not it’s necessary if you’ve already overcome the virus.
While the possibility of a viable COVID-19 vaccine is great news, we might not have the means to get our hands on it.
I’ll give you a clue – it fits nicely into the Spiderbait cover of the old work song ‘Black Betty’.
Vaccine breakthrough ‘great day for humanity’. Branson’s world first. Enter the McPlant. Talk of SA lockdown restrictions. Top SA restaurant shuts. Cape Town’s sextuplets.
COVID-19 vaccine trial paused. Clicks update. Boeing’s latest blunder. Mafia boss eats man’s finger. Nice dagga patch, Tito. Caster loses bid. Borat 2. Tom Cruise getting desperate.
A highly contagious and unpredictable virus like COVID-19 is tough to treat, but scientists are making some headway.
The University of Witwatersrand, in partnership with Oxford University, starts human trials this week for a possible COVID-19 vaccine.
Scientists at Oxford University are confident that they’ve developed the first workable COVID-19 vaccine, although much testing still lies ahead.
Bill Gates has some updates on his efforts to combat the coronavirus, and some insights into when we may expect a vaccine.
Jennifer Haller speaks out about what it was like to be the first person in the world to trial a possible vaccine for COVID-19.
You’ve probably heard about a vaccine that should take 12 to 18 months to roll out, but not all experts are convinced.